5AM Opportunities I, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1753000. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-02 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 7 filings — 1,856,285 shares, $23,860,543 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 688,358 shares @ $14.90 ($10,256,534) in Enliven Therapeutics, Inc., filed 2024-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | 10% owner | 2 | — | 4 legs · 1,325,000 sh · $19,792,500 | — |
| Entrada Therapeutics, Inc. (TRDA) | 10% owner | 5 | — | 13 legs · 531,285 sh · $4,068,043 | — |
Form 4 filings — 5AM Opportunities I, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M, Schwab Andrew J. | Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85 | EDGAR |
| 2026-08-03 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M, Schwab Andrew J. | Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85 | EDGAR |
| 2025-11-18 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M, Schwab Andrew J. | Sale (S): 200,000 @ $8.80 | EDGAR |
| 2025-07-11 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M, Schwab Andrew J. | Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50 | EDGAR |
| 2025-07-01 | 4 | Entrada Therapeutics, Inc. (TRDA) jointly with 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I (GP), LLC, ROCKLAGE SCOTT M, Schwab Andrew J. | Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12 | EDGAR |
| 2024-02-16 | 4 | Enliven Therapeutics, Inc. (ELVN) jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, PARMAR KUSH, Schwab Andrew J. | Sale (S): 688,358 @ $14.90 · Sale (S): 136,642 @ $14.90 | EDGAR |
| 2024-02-02 | 4 | Enliven Therapeutics, Inc. (ELVN) jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities I (GP), LLC, PARMAR KUSH, Schwab Andrew J. | Sale (S): 417,187 @ $15 · Sale (S): 82,813 @ $15 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1753000 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →